Discontinued — last reported Q2 '24
Illumina San Diego — Right-of-use assets and leasehold improvements decreased by 2.1% to $139.00M in Q2 2024 compared to the prior quarter.
An increase typically signals expansion of research or manufacturing capacity in the region, while a decrease may indicate consolidation, lease expirations, or asset impairment.
This metric represents the total carrying value of operating lease assets and associated capital improvements for facili...
Comparable to 'Right-of-Use Assets' or 'Leasehold Improvements' reported by other life science companies with significant R&D and manufacturing hubs in major biotech clusters.
ilmn_segment_san_diego_right_of_use_assets_and_leasehold_improvements| Q1 '24 | Q2 '24 | |
|---|---|---|
| Value | $142.00M | $139.00M |
| QoQ Change | — | -2.1% |